APLS - Apellis Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

APLS is currently covered by 17 analysts with an average price target of $38.38. This is a potential upside of $35.26 (1130.13%) from yesterday's end of day stock price of $3.12.

Apellis Pharmaceuticals's activity chart (see below) currently has 519 price targets and 385 ratings on display. The stock rating distribution of APLS is 68.75% BUY, 28.13% HOLD and 3.13% SELL.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 67.23% with an average time for these price targets to be met of 201.49 days.

Highest price target for APLS is $52, Lowest price target is $18, average price target is $38.38.

Most recent stock forecast was given by from CANTOR FITZGERALD on 15-May-2026. First documented stock forecast 04-Dec-2017.

Best performing analysts who are covering APLS - Apellis Pharmaceuticals:

Colleen Kusy Michael Ulz Elemer Piros Annabel Samimy Chris Howerton Matthew Luchini

Currently out of the existing stock ratings of APLS, 22 are a BUY (68.75%), 9 are a HOLD (28.13%), 1 are a SELL (3.13%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 15-May-2026

$31

5 months 13 days ago
(15-May-2026)

4/22 (18.18%)

$13.11 (73.28%)

308

Buy Since 20-Jan-2026

$41

$37.23 (987.53%)

$26

6 months 11 days ago
(17-Apr-2026)

15/18 (83.33%)

$0.1 (0.24%)

100

Hold Since 02-Nov-2023

$41

$37.23 (987.53%)

$20

6 months 26 days ago
(02-Apr-2026)

14/19 (73.68%)

$0.59 (1.46%)

147

Buy Since 02-Apr-2026

$41

$-0.03 (-0.07%)

$31

6 months 26 days ago
(02-Apr-2026)

2/2 (100%)

$0.59 (1.46%)

26

Buy Since 04-Dec-2017

$41

$37.23 (987.53%)

$44

6 months 27 days ago
(01-Apr-2026)

22/29 (75.86%)

$0.61 (1.51%)

214

Show more analysts

Please expand the browser size to see the chart

What is APLS (Apellis Pharmaceuticals) average time for price targets to be met?

On average it took 201 days for the stock forecasts to be reached, with an average price target met ratio of 67.23%.

Which analyst most recently updated their price target on APLS (Apellis Pharmaceuticals)?

Which analyst has the most public recommendations on APLS (Apellis Pharmaceuticals)?

has 0 price targets and 0 ratings on APLS

Which analyst is the currently most bullish on APLS (Apellis Pharmaceuticals)?

Akash Tewari with the highest potential upside of $78.23

Which analyst is the currently most reserved on APLS (Apellis Pharmaceuticals)?

Laura Chico with the lowest potential downside of -$23.03
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?